UNSPSC 51332841: Chlorpromazine maleate

This classification denotes a phenothiazine and antipsychotic agent with the molecular formula C17H19CLN2S.C4H4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q98X428KKM. European Medicines Agency schedules chlorpromazine maleate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01256MIG. Most nations, for tariff and trade purposes, schedule chlorpromazine maleate under HS 29343090 and SITC 51578. As of Q4 2014, CHLORPROMAZINE MALEATE remains US FDA's Preferred Term for this commodity.

SMILES: CN(C)CCCN1C2CCCCC2SC3C1CC(CC3)CL.C(=C\C(=O)O)\C(=O)O.

UNSPSC 51332841 Chlorpromazine maleate is a Commodity code that nominally covers a specific antipsychotic pharmaceutical, yet recent state and local opportunities in the available record show no direct solicitation for this drug. State and local procurement activity tagged to this code appears to reflect misclassification or system tagging errors rather than actual demand for chlorpromazine maleate itself. The issuing bodies visible in the recent record span county health departments, state health and human services commissions, and cooperative purchasing alliances serving multiple jurisdictions, but their actual procurement focus — naloxone systems, direct-to-manufacturer pharmacy programs, and generic multi-source pharmaceuticals broadly — does not align with this specific commodity.

The three recent opportunities posted between January and June 2026 show activity across Florida, Texas, and the Minnesota-Oregon multistate cooperative purchasing network, but none directly addresses chlorpromazine maleate procurement. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking naloxone and drug deactivation systems with a July 26, 2023 response deadline; the Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to explore direct-to-manufacturer prescription capabilities; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products with a March 26, 2026 due date. This code shows little relevant recent activity and does not appear to drive active procurement at the state and local level based on the available record.